Covered recipient · General Payments record
KATLYN T DIAMOND
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,514.53
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.92 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $72.26 | 4 |
| Lilly USA, LLC | $71.21 | 3 |
| Acerta Pharma LLC | $65.14 | 2 |
| Mylan Specialty L.P. | $49.07 | 1 |
| Exact Sciences Corporation | $42.04 | 2 |
| Amgen Inc. | $39.32 | 2 |
| GlaxoSmithKline, LLC. | $18.44 | 1 |
| PFIZER INC. | $16.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.50 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541198 | CMS |
| Amgen Inc. | $16.82 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541200 | CMS |
| AstraZeneca Pharmaceuticals LP | $40.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104464850 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.25 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105707814 | CMS |
| Exact Sciences Corporation | $19.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114561839 | CMS |
| Exact Sciences Corporation | $22.77 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114561843 | CMS |
| GlaxoSmithKline, LLC. | $18.44 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116034534 | CMS |
| Lilly USA, LLC | $18.34 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135765843 | CMS |
| Lilly USA, LLC | $27.63 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135759284 | CMS |
| Lilly USA, LLC | $25.24 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135787608 | CMS |
| Mylan Specialty L.P. | $49.07 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147359182 | CMS |
| Novo Nordisk Inc | $18.90 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437347 | CMS |
| Novo Nordisk Inc | $15.58 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100529581 | CMS |
| Novo Nordisk Inc | $23.36 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100517519 | CMS |
| Novo Nordisk Inc | $14.42 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100237770 | CMS |
| PFIZER INC. | $16.44 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132004116 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.